In our sample, all women diagnosed with hypothyroidism were treated with oral repositioning of the T4 hormone and had adequate hormone levels at the time of inclusion in the study; however, monitoring adherence to treatment and hormone levels during pregnancy was outside the scope of this study. The gene discussed is CD4; the disease is hypothyroidism.